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Abstract
Macrophages are essential to maintaining lung homoeostasis and recent work has demon-
strated that influenza-infected lung macrophages downregulate their expression of the scav-
enger receptor CD36. This receptor has also been shown to be involved in phagocytosis of
Streptococcus pneumoniae, a primary agent associated with pneumonia secondary to viral
infection. The aim of this study was to investigate the role of CD36 in the effects of viral infec-
tion on macrophage phagocytic function. Human monocyte-derived macrophages (MDM)
were exposed to H3N2 X31 influenza virus, M37 respiratory syncytial virus (RSV) or UV-irra-
diated virus. No infection of MDM was seen upon exposure to UV-irradiated virus but incuba-
tion with live X31 or M37 resulted in significant levels of viral detection by flow cytometry or
RT-PCR respectively. Infection resulted in significantly diminished uptake of S. pneumoniae
by MDM and significantly decreased expression of CD36 at both the cell surface and mRNA
level. Concurrently, there was a significant increase in IFNβ gene expression in response to
infection and we observed a significant decrease in bacterial phagocytosis (p = 0.031) and
CD36 gene expression (p = 0.031) by MDM cultured for 24 h in 50IU/ml IFNβ. Knockdown of
CD36 by siRNA resulted in decreased phagocytosis, but this was mimicked by transfection
reagent alone. When MDM were incubated with CD36 blocking antibodies no effect on
phagocytic ability was observed. These data indicate that autologous IFNβ production by
virally-infected cells can inhibit bacterial phagocytosis, but that decreased CD36 expression
by these cells does not play a major role in this functional deficiency.
Introduction
Respiratory infections are a leading cause of global morbidity and mortality. The especially
high mortality rates in the 1918–19 influenza pandemic have been ascribed in part to
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secondary bacterial infection of the airway leading to pneumonia [1]. The major bacterial
organism identified in these secondary bacterial pneumonias was Streptococcus pneumoniae
[1]. This bacterial pathogen is also a feature of complications of seasonal influenza outbreaks,
causing much of the morbidity and mortality associated with influenza on an annual basis [2].
Macrophages are key to the immune surveillance and defence of the human respiratory
tract, being responsible for phagocytosis and clearance of infectious organisms [3]. Bacterial
phagocytosis is a receptor-mediated event and numerous cell surface proteins have been impli-
cated in the uptake of bacteria by macrophages including the Macrophage Receptor with Col-
lagenous structure (MARCO) [4], CD36 [5] and CD206 [6]. There is increasing evidence that
not only are macrophages targets of influenza infection [1], but also that the ability of macro-
phages from infected lungs to eliminate bacteria is compromised [4, 7–9]. A recent study utilis-
ing whole-genomemicroarrays has analysed the response of alveolar macrophages to influenza
infection and has demonstrated a decrease in the gene expression of Dectin-1 (CLEC7A),Mac-
rophage Scavenger Receptor (MSR)-1, CD206 (aka Mannose Receptor C 1) and CD36, which
correlated with an inability of the macrophages to phagocytose zymosan [10].
CD36 is the prototypic class B scavenger receptor acting as a mediator of non-opsonic
phagocytosis [11]. This receptor has been linked with both bacterial phagocytosis and proin-
flammatory signalling, as well as binding numerous ligands including oxidised low-density
lipoproteins (oxLDL), thrombospondin-1 and long-chain fatty acids [5, 12–16]. CD36 has also
been shown to have a role in S. pneumoniae phagocytosis in mice [17]. However, the mecha-
nisms by which influenza infection affects CD36 expression and function of human macro-
phages has not been fully elucidated.
We have previously shown in an ex vivo lung model of influenza infection that influenza
virus has tropism for both epithelial cells and macrophages [18]. In the present study, we have
used a previously validated in vitromodel of lung macrophages [19] to further investigate the
role of CD36 in the effects of influenza infection on macrophage phagocytic function.
Materials and Methods
Ethics
The collection of lung tissue and bloodwas approved by and performed in accordance with the
ethical standards of the South Central—Hampshire A Research Ethics Committee (LREC no:
13/SC/0416).Written informed consent was obtained from all participants.
Monocyte isolation & differentiation
Monocytes were isolated from human peripheral bloodmononuclear cells (PBMC) and differ-
entiated into macrophages as previously described [19].
Infection of MDMs
Influenza A virus strain X31 was supplied at a concentration of 4 x 107 pfu/ml (a kind gift of
3VBiosciences). Inactivated virus (UVX31) was prepared by exposure of the X31 to an ultra-
violet (UV) light source for 2 h. Macrophages were incubated for 2 h with no virus, 500 pfu
(MDM) of X31 or UVX31. Cells were then washed and incubated for a further 22 h at 37°C,
5% CO2. Supernatants were harvested for cytokine analysis, HA shedding and LDH assays.
Cells were collected using non-enzymatic cell dissociation solution (Sigma, Poole, UK) for
immediate flow cytometry analysis or lysed and stored at -80°C for RNA analysis.
A similar method was used to infect MDMwith Respiratory Syncytial Virus (RSV—strain
M37—Meridian Life Science Inc, Memphis, USA). Inactivated RSV (UV-RSV) was prepared
Virus Inhibits Bacterial Phagocytosis
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by exposure of the RSV to an ultra-violet (UV) light source for 45 min. 500 μl of stock RSV (3.5
x 106 pfu) was diluted 1:1 in basal RPMI and a 1:10 dilution was made in each well and incu-
bated for 2 h at 37°C. MDMs were then washed with basal RPMI and cultured in reduced
serum (RS– 0.1%)-RPMI for a further 22 h.
Flow cytometry analysis
Samples were resuspended in FACS buffer (PBS, 0.5% w/v BSA, 2 mM EDTA) containing 2
mg/ml human IgG before being incubated on ice in the dark for 30 min in the presence of
fluorescently-labelled antibodies or isotype controls (all BD Biosciences, Oxford, UK). Intra-
cellular staining for viral nucleoprotein (NP)-1, was performed using BD Cytofix/Cytoperm
kit according to manufacturer’s instructions, and AlexaFluor 488 (AF488)-conjugated anti-
NP1 antibody (HB-65, a kind gift of 3VBiosciences). Intracellular staining for RSV F protein
was performed using BD Cytofix/Cytoperm kit according to manufacturer’s instructions,
RSV-F protein antibody (Meridian Life Science Inc). After incubation on ice for 30 min,
MDM were washed and incubated with AlexaFluor 488 anti-mouse antibody (Invitrogen,
Paisley, UK). Flow cytometric analysis was performed on a FACSAria using FACSDiva soft-
ware v5.0.3 (all BD).
Phagocytosis experiments
MDMwere infected with Streptococcus pneumoniae strain D39 serotype 2 at an MOI of 0.1
in RS-RPMI (without antibiotics) for 2 h in the presence or absence of 10 μg/ml CD36 block-
ing antibody or isotype control (Abcam, Cambridge, UK). MDMs were washed and incu-
bated for 30 min in antibiotic-containing RS-RPMI to remove extracellular bacteria. Cells
were then incubated in 1X Permwash (BD) for 20 min before vortexing and plating onto
blood agar.
RNA Isolation & RT-PCR
MDMwere harvested in peqGOLDTrifast (Peqlab Lutterworth, UK)) and stored at -80°C
prior to RNA extraction according to manufacturer’s instructions. RNA concentration was
determined by NanoDrop 1000 (Thermo Scientific,Wilmington, USA) and 250 ng was mixed
with 1X RT-buffer, 4mM dNTPs, 1X random primer, 50UMultiscribe Reverse Transcriptase
and 20U RNase inhibitor (all from ThermoFisher, Basingstoke, UK) before thermocycling to
generate cDNA. cDNA was diluted 1:10 and 1 μL mixed with 1X Taqman Universal MasterMix
II, 1X Taqman Gene Expression Assay buffer and 0.25 μL of primers for RSV N gene, CD36,
IFNβ and β2-microglobluin (β2M –all ThermoFisher), before undergoing qPCR. Gene expres-
sion was normalised to β2M and quantified using the ΔΔCTmethod.
Supernatant analyses
IFNβ concentrations in culture supernatants were measured by ELISA according to the manu-
facturer’s instructions (MSD, Gaithersberg, USA). Culture supernatants were analysed for IL-
10 by Luminex assay as per manufacturer’s instructions (Bio-Rad). LDH release was measured
using CytoTox 961 Non-Radioactivity Cytotoxicity Assay according to the manufacturer’s
instructions (Promega, Southampton, UK). Release of viral hemagglutinin was measured using
a dot blot assay on nitrocellulosemembrane detected using a rabbit polyclonal anti-influenza
serum. The bound rabbit antibodies were detected using the Bio-Rad anti-Rabbit HRP detec-
tion system according to the manufacturer’s instructions.
Virus Inhibits Bacterial Phagocytosis
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Transfection of MDM
HiPerfect immunocomplexes of 60 nM pooledCD36 siRNA sequences (Qiagen Crawley, UK)
or scrambled RNA (AllStars Neg. siRNA AF488 Qiagen) were vortexed and incubated in the
dark for 10 min at RT. MDMwere incubated at 37°C in 100 μl RS-RPMI containing the immu-
nocomplexes for 6 h before addition of 400 μl of RS-RPMI.MDMwere then incubated for a
further 18 h before further analysis. Transfection efficiencywas calculated by analysis of fluo-
rescently labelled scrambled RNA uptake by MDM using flow cytometry. The mean transfec-
tion efficiencywas 96.33% (n = 5).
Western blotting
After transfectionMDMs were lysed in 150 mMTris-HCl pH 8 containing 150 mMNaCl and
1% v/v Triton X-100. The lysates were agitated on ice for 30 min, before centrifugation at
12,000 g and supernatant harvest. Protein concentration was measured with the Pierce BCA
Protein Assay Kit (ThermoFisher) according to manufacturer’s instructions and 30 μg of pro-
tein was loaded into a NuPage Novex 4–12% Bis-Tris Protein Gel (ThermoFisher). Electropho-
resis was carried out at 200V for 1 h in NuPAGE MOPS SDS running buffer (ThermoFisher).
Protein was then transferred to a PVDFmembrane using the iBlot transfer system (Invitrogen)
according to manufacturer’s instructions. After transfer the membranes were blocked for 1 h at
RT in 5% non-fat drymilk (NFDM) in Tris-buffered saline (150mMNaCl, 50mM TrisHCl
pH7.5) with 0.1%v/v Tween-20 (TBST). Membranes were then washed with TBST and incu-
bated with either 1:1000 rabbit αCD36 (Abcam) or 1:50,000 α-β-actin-HRP (Abcam) for 1 h in
NFDM-TBST at RT. Membranes stained for CD36 protein were washed again in TBST and
incubated with 1:2000 goat α-rabbit-HRP (Sigma, Poole, UK) in NFDM-TBST for 1 h at RT.
The membranes were then developed in the Novex ECL Chemiluminescent Substrate Reagent
Kit (ThermoFisher) and imaged with the Chemidoc XRS imaging system (BioRad).
Statistics
Statistical analyses were performed using a Wilcoxon’s signed rank test or paired Student’s t-
test (GraphPad Prism v6, GraphPad Software Inc., San Diego, USA) as indicated. Results were
considered significant if p<0.05.
For a full description of all the methods used please see Supporting Information S1 Methods
Results
Virally infected monocyte-derived macrophages (MDM) have a specific
defect in bacterial phagocytosis
We infectedMDMmatured in the presence of 2 ng/ml GM-CSF for 12 d, as previously described
[19]. After maturation, GM-CSF containing media was removed and replaced with RS RPMI.
Cells were then incubated in the presence or absence (NT) of 500 pfu H3N2 X31 (X31) or UV-
inactivatedH3N2 X31 (UVX31) for 2 h. After a further 22 h, cells were collected and immedi-
ately analysed by flow cytometry. Using flow cytometry, 30% of MDMwere NP-1+ after 22 h
X31 infection, but no increase in NP-1 was detected in UVX31-exposedcells (Fig 1A and 1B).
We next investigated if influenza had an effect on phagocytosis in our MDMmodel. MDM
were infected as described above and after 24 h media was replaced and D39 S. pneumoniae
was added for 2 h. After extensive washing in antibiotic containing media, cells were lysed and
uptake of bacteria was assessed by culture. Phagocytosis of bacteria was significantly reduced in
X31-infectedMDMs by 92% (p = 0.0313), but not in UVX31 exposed cells (Fig 1C). Moreover
this inhibitory effect on phagocytosis was not limited to influenza, as infecting the MDMwith
Virus Inhibits Bacterial Phagocytosis
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RSV (Fig 2A–2C) also significantly reduced uptake of bacteria by 45% (p = 0.0469—Fig 2D).
However, influenza infection had no effect on the ability of MDMs to phagocytose latex micro-
spheres (See S1 Fig).
Effects of viral infection on CD36 expression by MDM
Since bacterial phagocytosis is a receptor mediated event, we analysed the expression of a range
of receptors known to be involved in phagocytosis by multichromatic flow cytometry. We
observedno significant difference in the surface expression of CD163 or CD206 but expression
of the scavenger receptor A (CD204) was increased in response to influenza infection (Fig 3).
In contrast, we observed a small but significant decrease in surface CD36 expression
(p = 0.0469) on the surface of infected cells but not cells exposed to UVX31 (Fig 4B). This
downregulation in CD36 surface expression was more pronounced at the level of mRNA
expression, with X31 infected cells expressing less than half the amount (mean 0.37 ± S.E. 0.13)
Fig 1. Effect of influenza infection on bacterial phagocytosis by MDM. MDM were differentiated in the presence of 2 ng/ml
GM-CSF for 12 d prior to infection with H3N2 X31 influenza virus or a UV-irradiated aliquot of virus (UVX31) for 2 h. After washing,
media was replaced and the cells incubated for a further 22 h before supernatants and cells were harvested for (A) & (B) influenza NP1
expression (% cells, n = 7) by flow cytometry. Phagocytosis of S. pneumonia was detected in (C) X31-infected (n = 5) MDM after a
further 2 h incubation with live bacteria by culture. (A) Representative flow cytometry plot of MDM expressing influenza NP1. Data are
expressed as means ±SE of n independent experiments and analysed using a Wilcoxon-signed rank test * p<0.05, ** p<0.01.
doi:10.1371/journal.pone.0163889.g001
Virus Inhibits Bacterial Phagocytosis
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of CD36 steady state mRNA after 24 h (Fig 4C). A similar decrease in CD36 mRNA was
also observed in RSV infectedMDM, although not quite to the same extent (mean 0.78 ± SE
0.06—Fig 4F), but both live and UV-inactivated RSV reduced surface expression of this recep-
tor (Fig 4E).
Blockade of viral replication reverses downregulation of CD36
To ascertain the stage during the influenza life cycle that was essential to the down regulation
of CD36, MDMwere pretreated for 1 h with oseltamivir phosphate (10 μM—Tam) and conca-
namycin A (10 nM—ConA) before addition of X31 for a further 2 h and these compounds
were added back to the media after the virus had been removed. Oseltamivir is a neuraminidase
inhibitor that prevents viral shedding [20], but this compound could not reverse the decreased
expression of CD36 on X31-infectedMDM (Fig 5B). ConA inhibits viral replication by inhibi-
tion of endosomal acidification [21] and this compound significantly inhibited NP-1 expres-
sion (Fig 5A, p = 0.016) and prevented the downregulation of CD36 by infectedMDM
Fig 2. Effect of RSV infection on bacterial phagocytosis by MDM. MDM were differentiated in the presence of 2 ng/ml GM-CSF for
12 d prior to infection with M37 RSV or a UV-irradiated aliquot of virus (UV-RSV) for 2 h. After washing, media was replaced and the
cells incubated for a further 22 h before supernatants and cells were harvested for (A) & (B) RSV-F protein expression (% cells, n = 10)
by flow cytometry or (C) RSV-N gene expression by RT-PCR (n = 7). Phagocytosis of S. pneumonia was detected in RSV-infected
(n = 6) MDM after a further 2 h incubation with live bacteria by culture. (A) Representative flow cytometry plot of MDM expressing RSV
F-protein. The units for RSV-N gene expression are 2ΔCT. Data are expressed as means ±SE of n independent experiments and
analysed using a Wilcoxon-signed rank test * p<0.05, ** p<0.01.
doi:10.1371/journal.pone.0163889.g002
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Fig 3. Effect of influenza infection on scavenger receptor expression by MDM. MDM were
differentiated in the presence of 2 ng/ml GM-CSF for 12 d prior to infection with H3N2 X31 influenza virus or
a UV-irradiated aliquot of virus (UVX31) for 2 h. After washing, media was replaced and the cells incubated
for a further 22 h before supernatants and cells were harvested for cell surface (A) CD206 expression (n = 5),
(B) CD163 expression (n = 5) or (C) CD204 expression by flow cytometry (n = 5). Data are expressed as
means ±SE of n independent experiments and analysed using a Wilcoxon-signed rank test * p<0.05.
doi:10.1371/journal.pone.0163889.g003
Virus Inhibits Bacterial Phagocytosis
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(p = 0.047—Fig 5C), suggesting replication of viral genes is essential in this process. Further-
more, we observed that in contrast to oseltamivir, ConA also significantly inhibited IFNβ
release by X31-infectedMDM (p = 0.031—Fig 5D).
Effects of autologous cytokines released in response to viral infection
As the downregulation of CD36 by MDMwas observedon the whole population of infected
cells this suggests that this downregulationmay be driven by autologous soluble factors. The
previous data using ConA (Fig 5D) implicated IFNβ in the influenza-induceddecrease of
CD36.We therefore investigated whether IFNβ alone could cause a reduction in CD36 mRNA
expression as well as bacterial phagocytosis in our model system. In agreement with our previ-
ous report [19], both influenza and RSV induced IFNβ gene expression fromMDM (Fig 6A
and 6C). When we incubated the MDM in 50 IU/ml IFNβ for 24 h we observed significant
inhibition of CD36 mRNA expression by MDM (p = 0.031—Fig 6B). This dose of IFNβ signifi-
cantly reduced the ability of MDM to phagocytose S. pneumoniae (p = 0.031—Fig 6D).
Fig 4. Effect of viral infection on CD36 expression by MDM. MDM were differentiated in the presence of 2 ng/ml GM-CSF for 12 d
prior to infection with (A) & (B) H3N2 X31 influenza virus or a UV-irradiated aliquot of virus (UVX31) or (C) & (D) M37 RSV or a UV-
irradiated aliquot of virus (UV-RSV) for 2 h. After washing, media was replaced and the cells incubated for a further 22 h before
supernatants and cells were harvested for (B) & (E) CD36 cell surface expression by flow cytometry (specific mean fluorescence
intensity–SMFI n = 6) by flow cytometry or (C) & (F) CD36 gene expression by RT-PCR (X31 n = 6, RSV n = 7). PCR data were
normalised to β2MG and are expressed as mean fold induction over the non-infected (NI) sample ± SEM. Representative flow
cytometry histograms of cell surface CD36 expression in response to (A) influenza infection and (D) RSV infection are shown.
Grey = NI, Blue = UV virus, Red = Live virus. Cell surface data are expressed as means ±SE of n independent experiments and
analysed using a Wilcoxon-signed rank test * p<0.05, ** p<0.01.
doi:10.1371/journal.pone.0163889.g004
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Previous work has also suggested a role for the anti-inflammatory cytokine, IL-10, in modu-
lating macrophage function after influenza infection [22]. However, there was a trend towards
decreased expression of IL-10 mRNA after 24 h infection by X31-infectedMDM (See S2 Fig).
Correspondingly, there was also no statistically significant increase of IL-10 release into the
supernatants of infectedMDMs (See S2 Fig).
CD36 blockade is dispensable for bacterial phagocytosis
To investigate the role of CD36 on bacterial phagocytosis, siRNA was used to knockdown
CD36 receptor expression by MDM. Specific siRNA targeting of CD36 caused a 92% reduction
in CD36 mRNA (Fig 7A) with a 64.3% decrease at the cell surface, as measured by flow cytom-
etry (Fig 7C). The agent used to deliver RNA, HiPerfect, was also shown to cause a small
(19%), but significant decrease in CD36 protein expression compared to the non-transfected
control. A correspondingly small, but not significant decrease in CD36 mRNA transcripts was
also observedwith empty HiPerfect.
Having demonstrated successful CD36 knockdown using this approach, S. pneumoniae
uptake was assessed in CD36 siRNA transfectedMDM (Fig 7D). Interestingly, a reduced
uptake of S. pneumoniae was observed for cells transfected with empty HiPerfect, as well as
those with CD36 siRNA. MDM transfected with RNA showed the greatest decrease in S. pneu-
moniae uptake. These results suggest that the transfection process itself affected the phagocytic
ability of macrophages.
Fig 5. Effects of influenza infection on MDM cytokine expression. MDM were differentiated in the presence of 2 ng/ml GM-CSF
for 12 d prior to infection with 500 pfu of H3N2 X31 influenza virus or a UV-irradiated aliquot of virus (UVX31) for 2 h in the presence
or absence of oseltamivir phosphate (Tam– 10 μM) or concanamycin A (ConA– 10 nM). After washing, media containing inhibitors
was replaced and the cells incubated for a further 22 h before supernatants and cells were harvested for (A) Viral NP1 expression
(% cells, n = 6) by flow cytometry, (B) release of hemagglutinin into supernatants (n = 6), (C) CD36 cell surface expression by flow
cytometry (SMFI–n = 6) and (D) IFNβ release by MSD are expressed as percentage of X31-infection (n = 6). Data are expressed as
means ±SE of n independent experiments. Data analysed using a Wilcoxon-signed rank test. * p<0.05.
doi:10.1371/journal.pone.0163889.g005
Virus Inhibits Bacterial Phagocytosis
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Since the HiPerfect reagent reduced CD36 surface expression (Fig 7C), these data could sug-
gest that CD36 plays a pivotal role in the phagocytosis of S. pneumoniae by MDM. In an
attempt to confirm this, we performedwestern blotting on transfectedMDM (Fig 7E). In con-
trast to the surface expression data, we observedno effect of either the HiPerfect alone or the
CD36 siRNA on total cellular expression of this protein, suggesting the surface loss of this pro-
tein in response to transfectionmay be due to CD36 internalisation. To further investigate the
role of CD36 in S. pneumoniae phagocytosis we incubated the MDM in the presence of an anti-
body that blocks the CD36 receptor for 30 min prior to exposure to the bacteria. Blocking the
CD36 receptor in this manner had no effect on the phagocytic ability of the MDM (Fig 7F).
Discussion
This study has demonstrated that respiratory viral infection of macrophages inhibits the ability
of these cells to phagocytose bacteria, and that this effect is likely driven by autologous release
of IFNβ. In addition, although the expression of the phagocytic receptor CD36 was decreased
by both viral infection and IFNβ, this receptor does not seem to be involved in the phagocytosis
of bacteria by human macrophages as inhibition of CD36 interaction with bacteria through the
use of blocking antibody had no effect on the uptake of bacteria by MDM.
Fig 6. Virus-induced expression of IFNβ and effect of IFNβ on bacterial phagocytosis. MDM were differentiated in the presence of 2
ng/ml GM-CSF for 12 d prior to infection with (A) H3N2 X31 influenza virus or a UV-irradiated aliquot of virus (UVX31) or (C) M37 RSV or a
UV-irradiated aliquot of virus (UV-RSV) for 2 h. After washing, media was replaced and the cells incubated for a further 22 h before
supernatants and cells were harvested for IFNβ gene expression by RT-PCR (X31 n = 9, RSV n = 7). MDM were differentiated for 12 d as
above before treatment without (NT) or with 50 IU/ml IFNβ for 24 h and (B) cells harvested for CD36 gene expression by RT-PCR (n = 5) or
(D) phagocytosis of S. pneumonia was detected after a further 2 h incubation with live bacteria by culture (n = 5). PCR data were
normalised to β2MG and are expressed as mean fold induction over the non-infected (NI) sample ± SEM. Data are expressed as means
±SE of n independent experiments and analysed using a Wilcoxon-signed rank test * p<0.05, ** p<0.01.
doi:10.1371/journal.pone.0163889.g006
Virus Inhibits Bacterial Phagocytosis
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Influenza infection of the airway has long been known to affect macrophage phagocytosis
and bacterial killing [23], but the question as to whether this was mediated by exogenous factors
or by infection of the macrophages themselves has remained open. Early studies demonstrated
that virus-induced suppression of antibacterial defences was mediated by lymphocytes [24]. Sub-
sequent studies suggested that it is the cytokines released by lymphocytes, such as IFNγ and IL-
10, that mediate the suppressive effects of the virus [4, 7, 22, 25]. However, influenza can infect
and replicate in human alveolar macrophages [26] and we have previously demonstrated that
macrophages are a target of influenza infection in a human lung explant model [19]. The
observedeffects of virus on phagocytic ability are unlikely to be a result of virus-inducedcell
death as we have previously demonstrated that the dose of virus used in our MDMmodel does
not cause increased cell death [19]. Furthermore,macrophages were shown to be relatively resis-
tant to influenza-inducedcell death [27]. Similarly to this previous study we have also observed
no decrease in the ability of influenza-infectedMDMs to take up fluorescent microspheres [27].
In contrast, the ability of MDMs to phagocytose live S. pneumoniae was significantly reduced,
suggesting different mechanisms for the uptake of latex beads and bacteria.
Previous murine studies have demonstrated a role for both IL-10 and IFNγ in this virus-
induced defect of phagocytosis [4, 22], yet we observedno expression of IFNγmRNA or release
Fig 7. Role of CD36 in bacterial phagocytosis by MDM. (A)-(E) MDM were differentiated in the presence of 2 ng/ml GM-CSF for 12 d
before transfection with non-specific siRNA or siRNA specific for CD36 for 24 h before cells were harvested for analysis of (A) CD36
mRNA expression by RT-PCR (n = 4) and (B) & (C) CD36 surface expression by flow cytometry (n = 6) or (D) phagocytosis of S.
pneumonia was detected after a further 2 h incubation with live bacteria by culture (n = 4). (E) Total cellular expression of CD36 was
assessed by western blot 24 h after transfection. β-actin is used as a loading control. Blot representative of 3 independent experiments.
(F) MDM were differentiated for 12 d as above before phagocytosis of S. pneumonia was detected in the presence or absence of 10 μg/
ml αCD36 blocking antibody or isotype control (ISO) after a further 2 h incubation with live bacteria by culture (n = 5). PCR data were
normalised to β2MG and are expressed as mean fold induction over the not treated (NT) sample ± SEM of n independent experiments.
B) Representative flow cytometry histograms of CD36 surface expression in response to transfection are shown. Grey = NT,
Blue = HiPerfect (HF), Red = CD36 siRNA. Flow cytometry and phagocytosis data are expressed as means ±SE of n independent
experiments. (A) & (C) Data analysed using a paired t-test ** p<0.01. (B) & (D) Data analysed using a Wilcoxon-signed rank test *
p<0.05.
doi:10.1371/journal.pone.0163889.g007
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in X31-infectedMDM [19] and a trend towards a virally-induceddecrease in IL-10 mRNA
expression. These results suggest that, in contrast to murine models of influenza infection, nei-
ther IFNγ nor IL-10 are playing a role in the decreased bacterial phagocytosis. However, we did
observe a possible role for virus-induced IFNβ release as a mediator of defective phagocytosis.
The effects of type I IFN on macrophage phagocytosis are somewhat understudied in the litera-
ture. Stimulation of type I IFNs by the TLR3 agonist PolyI:C has been shown to increase pneu-
mococcal nasopharyngeal colonisation in a murine model [8]. More recently in line with our
data, IFNβwas also demonstrated to decrease the ability of human MDM to phagocytose the
fungus,Candida albicans [28]. Intriguingly, IFNβwas previously reported to increase the abil-
ity of macrophages to phagocytose apoptotic cells [29]. These observations also have potential
implications for the use of IFNβ in the prevention of virus-induced exacerbations of asthma
[30], a disease already associated with decreased phagocytic function of macrophages [31].
Our data demonstrating influenza and RSV induced decreases in CD36 expression are in
line with a recent report of gene expression changes in alveolar macrophages in response to
influenza infection [10]. In addition, we are the first to report that IFNβ can also cause downre-
gulation of this receptor. In contrast, our data regarding the functional relevance of this CD36
downregulation on bacterial phagocytosis are not so clear cut. Using siRNA that specifically
targets CD36 we have demonstrated that we can reduce CD36 mRNA, cell surface expression
and bacterial phagocytosis. Surprisingly, the siRNA transfection reagent alone induced a small,
but significant, decrease in CD36 surface expression and subsequent reduction in bacterial
phagocytosis. As CD36 is known to be involved in recognition and uptake of lipids as well as
bacteria [11, 17] this could indicate that the HiPerfect, which is a mixture of cationic and neu-
tral lipids, may inhibit bacterial phagocytosis by acting as a CD36 blocking agent. However, we
observedno effect of the CD36 blocking antibody on bacterial phagocytosis, suggesting this
postulation is unlikely. Furthermore, we observedno effect of transfection on total cellular
expression of CD36 suggesting that this change at the cell surfacemay bemediated by interna-
lisation of the protein. A further possibility for this effect of HiPerfect is suggested by the role
of CD36 in the phagocytosis of apoptotic cells [32, 33]. In this case, HiPerfect may bemimick-
ing apoptotic cells which may lead to similar anti-inflammatory and tolerogenic pathways
being activated [34]. Further work is required to support this speculation.
The question remains is the virus-induceddecrease in bacterial phagocytosismediated by
decreased scavenger receptor expression? The microarray data from influenza-infectedalveolar
macrophages published by Wang et al (2012), demonstrated that Dectin-1, CD204, CD206 and
CD36 gene expression was decreased by infection [10]. Our data suggest no role for CD36,
CD204 or CD206 in decreased bacterial uptake in response to viral infection. Dectin-1 is a C-
type lectin that recognises fungal-derived glucans [10] and is therefore unlikely to be involved
in the uptake of bacteria. Intriguingly, there is a defect in the ability of macrophages derived
from patients with chronic obstructive pulmonary disease (COPD) to phagocytose bacteria
that was not associated with any changes in a similar panel of scavenger receptors [35]. Thus,
the decrease in phagocytic ability in response to viral infection and in COPDmay be receptor
independent. Further investigation into the mechanisms and pathways involved in decreased
bacterial phagocytosis are therefore required.
In summary, we have shown that whilst viral infection and IFNβ treatment of macrophages
downregulates both phagocytic ability and CD36 expression, the downregulation of CD36
appears to be uncoupled from bacterial phagocytosis. Instead, downregulation of this molecule
by virus-infectedMDMmay reflect an attempt by the macrophage to return to homeostasis by
reducing inflammatory potential since CD36 can mediate an inflammatory cascade [5]. The
data reported herein also have implications for the use of lipid-containing transfection reagents
for the study of pathways involved in bacterial phagocytosis.
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Supporting Information
S1 Fig. Viability and cell surfacemarker expression of infectedMDM.MDMwere infected
with X31 virus or UVX31 for 24 h before incubating with 0.4 μM YG latex microspheres at a
ratio of 2.5 microspheres:1 cell. Phagocytosis of fluorescent beads was measured by flow
cytometry. Data are expressed as means ± SE of 5 independent experiments and analysed using
a Wilcoxon-signed rank test.
(PPTX)
S2 Fig. Infection of MDM by influenza.MDMwere differentiated in the presence of 2 ng/ml
GM-CSF for 12 d prior to infectionwith H3N2 X31 influenza virus or a UV-irradiated aliquot
of virus (UVX31) for 2 h. After washing, media was replaced and the cells incubated for a fur-
ther 22 h before supernatants and cells were harvested for A) IL-10 gene expression by
RT-PCR (n = 4) or B) IL-10 release (n = 6) by Luminex ELISA analysis of culture supernatants.
PCR data were normalised to β2MG and are expressed as mean fold induction over the non-
infected (NI) sample ± SEM. Data are expressed as means ±SE of n independent experiments
and analysed using a Wilcoxon-signed rank test.
(PPTX)
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